A detailed history of Profund Advisors LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 48,558 shares of HUMA stock, worth $218,996. This represents 0.01% of its overall portfolio holdings.

Number of Shares
48,558
Previous 20,271 139.54%
Holding current value
$218,996
Previous $97,000 172.16%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.11 - $9.46 $144,546 - $267,595
28,287 Added 139.54%
48,558 $264,000
Q2 2024

Aug 13, 2024

BUY
$2.87 - $9.1 $58,177 - $184,466
20,271 New
20,271 $97,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $465M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.